Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 14/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 15/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 14/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 13/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 12/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 12/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 12/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 12/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 12/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 12/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 12/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL446509 | 0.88 | HDAC6 (0.57) | HDAC6HDAC1HDAC8HDAC2HDAC3 | |
| SCHEMBL446510 | 0.87 | HDAC6 (0.56) | HDAC6HDAC1HDAC8HDAC2HDAC3 | |
| SCHEMBL448108 | 0.87 | HDAC6 (0.63) | HDAC6HDAC1HDAC8HDAC2HDAC3 | |
| SCHEMBL450151 | 0.87 | HDAC6 (0.58) | HDAC6HDAC1HDAC8HDAC2HDAC3 | |
| SCHEMBL448030 | 0.85 | HDAC3 (0.49) | HDAC6HDAC1HDAC8HDAC2HDAC3 | |
| SCHEMBL449694 | 0.84 | HDAC6 (0.58) | HDAC6HDAC1HDAC8HDAC2HDAC3 | |
| SCHEMBL449553 | 0.80 | HDAC6 (0.55) | HDAC6HDAC1HDAC8HDAC2HDAC3 | |
| SCHEMBL2224872 | 0.77 | HDAC6 (1.00) | HDAC6HDAC1HDAC8HDAC2HDAC3 | |
| SCHEMBL452164 | 0.77 | HDAC6 (0.48) | HDAC6HDAC1HDAC8HDAC2HDAC3 | |
| SCHEMBL449644 | 0.77 | HDAC3 (0.46) | HDAC6HDAC1HDAC8HDAC2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2429987-A2 | AMIDE COMPOUND, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Korea Research Institute Of Chemical Technology (KR) | 2012-03-21 | — | — | EP | claimed |
| US-20120065396-A1 | ISOINDOLINONE DERIVATIVES, PREPARATION METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2012-03-15 | — | — | US | claimed |
| WO-2010131922-A2 | AMIDE COMPOUND, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2010-11-18 | — | — | WO | claimed |
| US-12002595-B2 | Separation of metal ions by liquid-liquid extraction | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-04 | — | — | US | disclosed |
| EP-4290532-A2 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | The Regents of the University of California (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-3520117-B1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | UNIV CALIFORNIA (US) | 2023-11-08 | — | — | EP | disclosed |
| US-20220160904-A1 | CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-05-26 | — | — | US | disclosed |
| US-11235076-B2 | Chelating platform for delivery of radionuclides | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-02-01 | — | — | US | disclosed |
| US-20210009510-A1 | CHELATING MOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-01-14 | — | — | US | disclosed |
| US-20190287691-A1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-09-19 | — | — | US | disclosed |
| EP-3520117-A2 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | The Regents of The University of California (US) | 2019-08-07 | — | — | EP | disclosed |
| US-20110031438-A1 | METHODS AND COMPOSITIONS FOR OBTAINING HIGH-RESOLUTION CRYSTALS OF MEMBRANE PROTEINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-02-10 | — | — | US | disclosed |
| US-20110009603-A1 | Method and composition for crystallizing G protein-coupled receptors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-13 | — | — | US | disclosed |
| WO-2010131922-A2 | AMIDE COMPOUND, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010131922-A2 | AMIDE COMPOUND, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2010-11-18 | — | — | WO | disclosed |
| US-7790850-B2 | comprising a fusion protein comprising a first portion of a GPCR, where the first portion comprises the TM1, TM2, TM3, TM4 and TM5 regions of the GPCR, a stable folded protein insertion and a second portion of the GPCR, where the second portion comprises the TM6 and TM7 regions | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2010-09-07 | — | — | US | disclosed |
| WO-2009055512-A9 | METHODS AND COMPOSTIONS FOR OBTAINING HIGH-RESOLUTION CRYSTALS OF MEMBRANE PROTEINS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2010-08-26 | — | — | WO | disclosed |
| EP-2203475-A2 | METHODS AND COMPOSTIONS FOR OBTAINING HIGH-RESOLUTION CRYSTALS OF MEMBRANE PROTEINS | The Scripps Research Institute (US) | 2010-07-07 | — | — | EP | disclosed |
| US-20090118474-A1 | Method and composition for crystallizing G protein-coupled receptors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-05-07 | — | — | US | disclosed |
| WO-2009055512-A2 | METHODS AND COMPOSTIONS FOR OBTAINING HIGH-RESOLUTION CRYSTALS OF MEMBRANE PROTEINS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2009-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190287691-A1 | SEPARATION OF METAL IONS BY LIQUID-LIQUID EXTRACTION | SLC39A14, SLC39A11, SLC39A7 | HDAC6 1254/4885HDAC1 2128/4885HDAC8 2003/4885 |
| US-11235076-B2 | Chelating platform for delivery of radionuclides | SLC40A1, TFRC, SLC39A14 | HDAC6 2473/4885HDAC1 2856/4885HDAC8 1995/4885 |
| US-20220160904-A1 | CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES | SLC40A1, TFRC, SLC39A14 | HDAC6 2473/4885HDAC1 2856/4885HDAC8 1995/4885 |
| US-20210009510-A1 | CHELATING MOLECULES | SLC39A3, SLC30A6, SLC30A7 | HDAC6 530/4885HDAC1 946/4885HDAC8 542/4885 |
| US-12002595-B2 | Separation of metal ions by liquid-liquid extraction | SLC39A14, SLC39A11, SLC39A7 | HDAC6 1254/4885HDAC1 2128/4885HDAC8 2003/4885 |
| US-20120065396-A1 | ISOINDOLINONE DERIVATIVES, PREPARATION METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION COMPRISING SAME | PPIP5K2, SOST, ALPL | HDAC6 467/4885HDAC1 761/4885HDAC8 1074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.